Inhibrx Biosciences, Inc.INBXNASDAQ
Loading
Cash generated from core business operations
Latest
$-129.79M
↓ 52% vs avg
Percentile
P22
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-85.31M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-129.79M | +33.2% |
| 2024 | $-194.41M | -0.6% |
| 2023 | $-193.31M | -67.7% |
| 2022 | $-115.30M | -43.5% |
| 2021 | $-80.32M | -67.5% |
| 2020 | $-47.97M | -49.5% |
| 2019 | $-32.08M | -38.9% |
| 2018 | $-23.09M | -23.1% |
| 2017 | $-18.75M | -3.6% |
| 2016 | $-18.11M | - |